Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation

British Journal of Cancer

Volumn 89, Issue 4, 2003, Pages 713-719

  Klapper, W ^a   Krams, M ^a   Qian, W ^a,b   Janssen, D ^a   Parwaresch, R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

hPif1; non Hodgkin lymphoma; Tankyrase; Telomerase; TRF1; TRF2

Indexed keywords

BINDING PROTEIN; PIF1 PROTEIN; PROTEIN; RNA DIRECTED DNA POLYMERASE; TANKYRASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

ARTICLE; BURKITT LYMPHOMA; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOME LOSS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN TISSUE; LYMPH NODE; NONHODGKIN LYMPHOMA; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERE; TRANSCRIPTION REGULATION; UPREGULATION;

CELL DIVISION; DNA HELICASES; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LYMPHOMA, B-CELL; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; RNA, NEOPLASM; SACCHAROMYCES CEREVISIAE PROTEINS; TANKYRASES; TELOMERASE; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TUMOR MARKERS, BIOLOGICAL;

EID: 0041733555     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601112     Document Type: Article

References (44)

1. Belair CD, Yeager TR, Lopez PM, Reznikoff CA (1997) Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 94: 13677-13682
2. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569-573
3. Bonatz G, Klapper W, Barthe A, Heidorn K, Jonat W, Krupp G, Parwaresch R (1998) Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium. Biochem Biophys Res Commun 253: 214-221
4. Brousset P, al Saati T, Chaouche N, Zenou RC, Schlaifer D, Chittal S, Delsol G (1997) Telomerase activity in reactive and neoplastic lymphoid tissues: infrequent detection of activity in Hodgkin's disease. Blood 89: 26-31
5. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248
6. Buchkovich KJ, Greider CW (1996) Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 7: 1443-1454
7. Corey DR (2002) Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene 21: 631-637
8. Damm K, Hemmann U, Garin-Chesa P, Hauel N, Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard B, Lauritsch I, Muller E, Pascolo E, Sauter G, Pantic M, Martens UM, Wenz C, Lingner J, Kraut N, Rettig WJ, Schnapp A (2001) A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J 20: 6958-6968
9. Dunham MA, Neumann AA, Fasching CL, Reddel RR (2000) Telomere maintenance by recombination in human cells. Nat Genet 26: 447-450
10. Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM (2000) Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer 89: 445-452
11. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18: 1219-1226
12. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, De Lange T (1999) Mammalian telomeres end in a large duplex loop. Cell 97: 503-514
13. Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481
14. Heidebrecht HJ, Buck F, Steinmann J, Sprenger R, Wacker HH, Parwaresch R (1997) p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M. Blood 90: 226-233
15. Herrera E, Martinez A, Blasco MA (2000) Impaired germinal center reaction in mice with short telomeres. EMBO J 19: 472-481
16. Karlseder J, Smogorzewska A, De Lange T (2002) Senescence induced by altered telomere state, not telomere loss. Science 295: 2446-2449
17. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
18. Klapper W, Singh KK, Heidorn K, Parwaresch R, Krupp G (1998) Regulation of telomerase activity in quiescent immortalized human cells. Biochim Biophys Acta 1442: 120-126
19. Klingelhutz AJ (1997) Telomerase activation and cancer. J Mol Med 75: 45-49
20. Krams M, Claviez A, Heidorn K, Krupp G, Parwaresch R, Harms D, Rudolph P (2001) Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Am J Pathol 159: 1925-1932
21. Kreipe H, Heidebrecht HJ, Hansen S, Rohlk W, Kubbies M, Wacker HH, Tiemann M, Radzun HJ, Parwaresch R (1993a) A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Am J Pathol 142: 3-9
22. Kreipe H, Wacker HH, Heidebrecht HJ, Haas K, Hauberg M, Tiemann M, Parwaresch R (1993b) Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen. Am J Pathol 142: 1689-1694
23. Krupp G, Klapper W, Parwaresch R (2000) Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation. Cell Mol Life Sci 57: 464-486
24. Krupp G, Kuhne K, Tamm S, Klapper W, Heidorn K, Rott A, Parwaresch R (1997) Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay. Nucleic Acids Res 25: 919-921
25. Kuppers R, Klein U, Hansmann ML, Rajewsky K (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341: 1520-1529
26. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 28: 669-677
27. Lin Z, Lim S, Viani MA, Sapp M, Lim MS (2001) Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am J Pathol 159: 711-719
28. Norrback KF, Dahlenborg K, Carlsson R, Roos G (1996) Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 88: 222-229
29. Norrback KF, Hultdin M, Dahlenborg K, Osterman P, Carlsson R, Roos G (2001) Telomerase regulation and telomere dynamics in germinal centers. Eur J Haematol 67: 309-317
30. Pardue ML, Debaryshe PG (1999) Telomeres and telomerase: more than the end of the line. Chromosoma 108: 73-82
31. Remes K, Norrback KF, Rosenquist R, Mehle C, Lindh J, Roos G (2000) Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer 82: 601-607
32. Rudolph P, Knuchel R, Endl E, Heidebrecht HJ, Hofstader F, Parwaresch R (1998) The immunohistochemical marker Ki-S2: cell cycle kinetics and tissue distribution of a novel proliferation-specific antigen. Mod Pathol 11: 450-456
33. Smith S, De Lange T (2000) Tankyrase promotes telomere elongation in human cells. Curr Biol 10: 1299-1302
34. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G, De Lange T (2000) Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659-1668
35. Stansel RM, De Lange T, Griffith JD (2001) T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 20: 5532-5540
36. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58: 4168-4172
37. van Steensel B, De Lange T (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743
38. van Steensel B, Smogorzewska A, De Lange T (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401-413
39. Wang J, Xie LY, Allan S, Beach D, Hannon GJ (1998) Myc activates telomerase. Genes Dev 12: 1769-1774
40. Weng N (1999) Telomeres, telomerase, and lymphocyte replicative life span. Clin Immunol 92: 1-2
41. Weng NP, Granger L, Hodes RJ (1997) Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci USA 94: 10827-10832
42. Weng NP, Levine BL, June CH, Hodes RJ (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183: 2471-2479
43. Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M (2001) Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci USA 98: 3826-3831
44. Zhou J, Monson EK, Teng S, Schulz VP, Zakian VA (2000) Pif1p helicase, a catalytic inhibitor of telomerase in yeast. Science 289: 771-774